CLINICAL_TRIALS
trial_result
· 2016-03-17
Clinical Trial Update: Epinephrine Inhalation Aerosol USP, CLINICAL STUDY-B3 FOR ASSESSMENT OF PHARMACOKINETICS [Phase 2]
Summary
A Phase 2 pharmacokinetics study of Epinephrine Inhalation Aerosol USP in asthma has been completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Amphastar Pharmaceuticals, Inc. | Conditions: Asthma | Phase 2 | Status: COMPLETED